Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid for Reducing Urinary Tract Infections After Neobladder Reconstruction
NCT02034890Phase 4Withdrawn
- Sponsor
- Rabin Medical Center
- Start
- Jul 2015
- Primary completion
- Mar 2017
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronic acid in urinary tract infection (UTI), sponsored by Rabin Medical Center. Planned start Jul 2015; status: withdrawn.
02
Drugs
hyaluronic acid
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02034890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034890.